Daily aspirin reduces cancer risk for Lynch patients

11/8/2009 | Medscape (free registration)

Lynch syndrome patients who took 600 milligrams of aspirin daily reduced by about half their risk of developing cancer, according to a British study. Researchers said the protection correlated with the length of aspirin use but said the therapy does carry an increased risk of hemorrhage.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD